WMA
BPMC

West Michigan Advisors’s Blueprint Medicines BPMC Stock Holding History

West Michigan Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-37
Closed -$1.86K – 157
2023
Q3 		$1.86K Buy
+37
New +$1.98K ﹤0.01% 151

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

West Michigan Advisors's BPMC Position: Q4 2023 in Review

West Michigan Advisors sold out of Blueprint Medicines (BPMC) in Q4 2023, closing a stake of 37 shares — an estimated $1.86K sold.

West Michigan Advisors first reported a position in BPMC in Q3 2023 and held it in 1 quarter. The position peaked at $1.86K in Q3 2023. 259 funds tracked by Wall St. Rank hold BPMC as of Q4 2023.

  • West Michigan Advisors reported no remaining Blueprint Medicines position as of Q4 2023 after selling out during the quarter.
  • West Michigan Advisors sold 37 Blueprint Medicines shares in Q4 2023, an estimated $1.86K.
  • West Michigan Advisors first reported a position in Blueprint Medicines in Q3 2023 and held it in 1 quarter.
  • West Michigan Advisors's Blueprint Medicines position peaked at $1.86K in Q3 2023.
  • 259 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2023.

Based on West Michigan Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.